The DOI matches its Crossref record; 129 of the 130 references it cites were found in a registry or an index.
Dengue: a continuing global threat
Open accessAbstract
Dengue fever and dengue haemorrhagic fever are important arthropod-borne viral diseases. Each year, there are ∼50 million dengue infections and ∼500,000 individuals are hospitalized with dengue haemorrhagic fever, mainly in Southeast Asia, the Pacific and the Americas. Illness is produced by any of the four dengue virus serotypes. A global strategy aimed at increasing the capacity for surveillance and outbreak response, changing behaviours and reducing the disease burden using integrated vector management in conjunction with early and accurate diagnosis has been advocated. Antiviral drugs and vaccines that are currently under development could also make an important contribution to dengue control in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Until recent advances in vaccine development [16–17], and the approval and potential availability of the first product in 2016 [18], dengue has been unique among the major vector-borne diseases, in that prevention from infection could only be attempted by reducing or eliminating bites by infected vector mosquitoes [19, 20].”
From Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis (2016) · cites this paper as [20]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Although a vaccine could be available as early as 2016, vector control remains the primary approach used to prevent dengue, the most common and widespread arbovirus of humans worldwide.”
From Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis (2016) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dengue and Dengue Hemorrhagic Fever
Gubler, D. J. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.480 · Cited by 4,310
Self-citationLanciotti, R. S., Calisher, C. H., Gubler, D. J., Chang, G. J., & Vorndam, A. V. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.3.545-551.1992 · Cited by 1,818 · cited 1×
“The most E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s commonly used NAATs are based on a single RT-PCR assay 95,96 , a nested RT-PCR assay 96 or a one-step multiplex RT-PCR assay 97 .”
MethodSelf-citationDengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity
Vaughn, D. W., Green, S., Kalayanarooj, S., Innis, B. L., Nimmannitya, S., Suntayakorn, S., Endy, T. P., Raengsakulrach, B., Rothman, A. L., Ennis, F. A., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315215 · Cited by 1,632 · cited 1×
“One advantage of this assay is the ability to determine viral titre early in dengue illness, which is believed to be an important predictor of disease severity 102 .”
BackgroundGuzmán, M. G., & Kouri, G. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00171-2 · Cited by 1,163
Spectrum of Disease and Relation to Place of Exposure among Ill Returned Travelers
Freedman, D. O., Weld, L. H., Kozarsky, P. E., Fisk, T., Robins, R., von Sonnenburg, F., Keystone, J. S., Pandey, P., & Cetron, M. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051331 · Cited by 1,081
Dengue and dengue haemorrhagic fever
Rigau-Pérez, J. G., Clark, G. G., Gubler, D. J., Reiter, P., Sanders, E. J., & Vance Vorndam, A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)12483-7 · Cited by 1,051
Self-citationCross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
Dejnirattisai, W., Jumnainsong, A., Onsirisakul, N., Fitton, P., Vasanawathana, S., Limpitikul, W., Puttikhunt, C., Edwards, C., Duangchinda, T., Supasa, S., et al. (2010) · Science · doi:10.1126/science.1185181 · Cited by 943 · cited 1×
“The available data suggest that neutralizing antibodies are the major contributors to protective immunity 124,125 , however the role of the cellular immune response requires further study 123 .”
BackgroundCalisher, C. H., Karabatsos, N., Dalrymple, J. M., Shope, R. E., Porterfield, J. S., Westaway, E. G., & Brandt, W. E. (1989) · Journal of General Virology · doi:10.1099/0022-1317-70-1-37 · Cited by 893 · cited 1×
“These tests are mainly for research and vaccine studies 90–94 .”
BackgroundOriginal antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever
Mongkolsapaya, J., Dejnirattisai, W., Xu, X.-N., Vasanawathana, S., Tangthawornchaikul, N., Chairunsri, A., Sawasdivorn, S., Duangchinda, T., Dong, T., Rowland-Jones, S., et al. (2003) · Nature Medicine · doi:10.1038/nm887 · Cited by 821 · cited 1×
“…CD4 + and CD8 + cells that have a diminished capacity to kill but nonetheless release inflammatory cytokines that contribute to disease severity 51 ; that severe disease is caused by DENVs of increased virulence 52 ; and the suggestion that cross-reactivity between NS1 and human platelets and…”
BackgroundDengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody
Halstead, S., & O'Rourke, E. (1977) · The Journal of Experimental Medicine · doi:10.1084/jem.146.1.201 · Cited by 804 · cited 5×
“Both in vitro and in vivo , macrophages and monocytes participate in antibody-dependent enhancement (ADE) 18–20 .”
BackgroundInfluentialSelf-citationEffect of Temperature on the Vector Efficiency of Aedes aegypti for Dengue 2 Virus
Watts, D. M., Burke, D. S., Harrison, B. A., Whitmire, R. E., & Nisalak, A. (1987) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1987.36.143 · Cited by 759 · cited 1×
“The virus passes from the mosquito intestinal tract to the salivary glands after an extrinsic incubation period, a process that takes approximately 10 days and is most rapid at high ambient temperatures 14 .”
BackgroundInnis, B. L., Nisalak, A., Nimmannitya, S., Kusalerdchariya, S., Chongswasdi, V., Suntayakorn, S., Puttisri, P., & Hoke, C. H. (1989) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1989.40.418 · Cited by 711 · cited 5×
“By contrast, during a secondary infection, high levels of IgG antibodies that crossreact with many flaviviruses are detectable even in the acute phase and rise dramatically over the following 2 weeks 65 .”
BackgroundMethodInfluentialHuman skin Langerhans cells are targets of dengue virus infection
Wu, S.-J. L., Grouard-Vogel, G., Sun, W., Mascola, J. R., Brachtel, E., Putvatana, R., Louder, M. K., Filgueira, L., Marovich, M. A., Wong, H. K., et al. (2000) · Nature Medicine · doi:10.1038/77553 · Cited by 666 · cited 2×
“Host factors that increase the risk of severe dengue disease include female sex, several human leukocyte antigen (HLA) class I alleles, a promoter variant of the DC-SIGN receptor gene, a single-nucleotide polymorphism in the tumour necrosis factor (TNF) gene and AB blood group 31–36 .”
BackgroundProspects for a dengue virus vaccine
Whitehead, S. S., Blaney, J. E., Durbin, A. P., & Murphy, B. R. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1690 · Cited by 623 · cited 1×
“The ideal dengue vaccine should be free of important reactogenicity, induce life-long protection against infection with any of the four DENV serotypes and be affordable 126,127 .”
BackgroundJessie, K., Fong, M. Y., Devi, S., Lam, S. K., & Wong, K. T. (2004) · The Journal of Infectious Diseases · doi:10.1086/383043 · Cited by 613 · cited 1×
“There is also evidence of abundant replication of DENVs in liver parenchymal cells and in macrophages in lymph nodes, liver and spleen, as well as in peripheral blood monocytes 17 .”
BackgroundBeltramello, M., Williams, K. L., Simmons, C. P., Macagno, A., Simonelli, L., Quyen, N. T. H., Sukupolvi-Petty, S., Navarro-Sanchez, E., Young, P. R., de Silva, A. M., et al. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.08.007 · Cited by 592
Self-citationKliks, S. C., Nimmanitya, S., Nisalak, A., & Burke, D. S. (1988) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1988.38.411 · Cited by 578 · cited 1×
“These non-neutralizing antibodies result from previous heterotypic dengue infections or from low concentrations of dengue antibodies of maternal origin in infant sera 21 .”
BackgroundHalstead, S. B., Nimmannitya, S., & Cohen, S. N. (1970) · PubMed Central · Cited by 572
Self-citationYoung, P. R., Hilditch, P. A., Bletchly, C., & Halloran, W. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.3.1053-1057.2000 · Cited by 542 · cited 1×
“Additional independent studies are needed to confirm the performance of these kits and to further validate the diagnostic and prognostic significance of NS1 and NS1-specific antibody detection 107–109 .”
Avirutnan, P., Punyadee, N., Noisakran, S., Komoltri, C., Thiemmeca, S., Auethavornanan, K., Jairungsri, A., Kanlaya, R., Tangthawornchaikul, N., Puttikhunt, C., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/500949 · Cited by 509 · cited 4×
“Recent publications have suggested that the WHO syndromic case definition of DHF/DSS should be evaluated for clinical utility 58–62 .”
BackgroundInfluentialJohnson, B. W., Russell, B. J., & Lanciotti, R. S. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.10.4977-4983.2005 · Cited by 494 · cited 1×
“Many real-time RT-PCR assays have been developed that are either ‘singleplex’, detecting one single serotype per reaction, or ‘multiplex’, identifying all four serotypes from a single sample 99–101 .”
The changing epidemiology of yellow fever and dengue, 1900 to 2003: full circle?
Gubler, D. J. (2004) · Comparative Immunology, Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2004.03.013 · Cited by 455 · cited 2×
“It is estimated that more than 50 million infections occur each year, including 500,000 hospitalizations for dengue haemorrhagic fever, mainly among children, with the case fatality rate exceeding 5% in some areas 1–4 .”
BackgroundSelf-citationGuidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses
Roehrig, J. T., Hombach, J., & Barrett, A. D. T. (2008) · Viral Immunology · doi:10.1089/vim.2008.0007 · Cited by 450 · cited 1×
“These tests are mainly for research and vaccine studies 90–94 .”
BackgroundEvolutionary Relationships of Endemic/Epidemic and Sylvatic Dengue Viruses
Wang, E., Ni, H., Xu, R., Barrett, A. D. T., Watowich, S. J., Gubler, D. J., & Weaver, S. C. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3227-3234.2000 · Cited by 445 · cited 1×
“DENV-1–4 evolved in non-human primates from a common ancestor and each entered the urban cycle independently an estimated 500–1,000 years ago 12 .”
BackgroundSelf-citationIn Vivo Enhancement of Dengue Virus Infection in Rhesus Monkeys by Passively Transferred Antibody
Halstead, S. B. (1979) · Journal of Infectious Diseases · doi:10.1093/infdis/140.4.527 · Cited by 438
Self-citationDengue Virus–Mosquito Interactions
Halstead, S. B. (2008) · Annual Review of Entomology · doi:10.1146/annurev.ento.53.103106.093326 · Cited by 438 · cited 1×
“Despite these differences, each serotype causes nearly identical syndromes in humans and circulates in the same ecological niche 13 .”
BackgroundSelf-citationBrengues, C., Hawkes, N. J., Chandre, F., Mccarroll, L., Duchon, S., Guillet, P., Manguin, S., Morgan, J. C., & Hemingway, J. (2003) · Medical and Veterinary Entomology · doi:10.1046/j.1365-2915.2003.00412.x · Cited by 432 · cited 1×
“Since the early 1970s the organophosphate temephos has been widely used, but increasing levels of resistance 114,115 , householders’ rejection of the treatment of their drinking water, and difficulties in achieving high and regular levels of coverage are important technical and operational…”
BackgroundWilder-Smith, A., & Schwartz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041927 · Cited by 423 · cited 1×
“Travellers from endemic areas might serve as vehicles for further spread 6–9 .”
BackgroundMicroevolution and virulence of dengue viruses
Rico-Hesse, R. (2003) · Advances in Virus Research · doi:10.1016/s0065-3527(03)59009-1 · Cited by 422 · cited 1×
“…but nonetheless release inflammatory cytokines that contribute to disease severity 51 ; that severe disease is caused by DENVs of increased virulence 52 ; and the suggestion that cross-reactivity between NS1 and human platelets and endothelial cells raises antibodies that damage these cells 53 .”
BackgroundThe WHO dengue classification and case definitions: time for a reassessment
Deen, J. L., Harris, E., Wills, B., Balmaseda, A., Hammond, S. N., Rocha, C., Dung, N. M., Hung, N. T., Hien, T. T., & Farrar, J. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69006-5 · Cited by 404
Self-citationDengue diagnosis, advances and challenges
Guzmán, M. G., & Kourı́, G. (2004) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2003.03.003 · Cited by 374 · cited 3×
“After an incubation period permitting virus replication, viral identification is performed using dengue-specific monoclonal antibodies in immunofluorescence and PCR assays 63,64,72,73 .”
BackgroundMethodGoncalvez, A. P., Engle, R. E., St. Claire, M., Purcell, R. H., & Lai, C.-J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703498104 · Cited by 364 · cited 1×
“Both in vitro and in vivo , macrophages and monocytes participate in antibody-dependent enhancement (ADE) 18–20 .”
BackgroundDengue: defining protective versus pathologic immunity
Rothman, A. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421512 · Cited by 364 · cited 1×
“The ideal dengue vaccine should be free of important reactogenicity, induce life-long protection against infection with any of the four DENV serotypes and be affordable 126,127 .”
BackgroundDengue Hemorrhagic Fever in Cuba, 1981: A Retrospective Seroepidemiologic Study
Guzmán, M. G., Kouri, G. P., Bravo, J., Soler, M., Vazquez, S., & Morier, L. (1990) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1990.42.179 · Cited by 348 · cited 2×
“Some outbreaks of primary DENV-2 infections have been predominantly subclinical 24 .”
BackgroundEffect of age on outcome of secondary dengue 2 infections
Guzmán, M. G., Kouri, G., Bravo, J., Valdes, L., Susana, V., & Halstead, S. B. (2002) · International Journal of Infectious Diseases · doi:10.1016/s1201-9712(02)90072-x · Cited by 328 · cited 1×
“The severity of DSS is age-dependent, with vascular leakage being most severe in young children, a phenomenon that is thought to be related to the intrinsic integrity of the capillaries 26,27 .”
BackgroundSelf-citationEpidemiologic Studies on Dengue in Santiago de Cuba, 1997
Guzman, M. G. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.9.793 · Cited by 320 · cited 1×
“Some outbreaks of primary DENV-2 infections have been predominantly subclinical 24 .”
BackgroundImpact of Dengue/Dengue Hemorrhagic Fever on The Developing World
Gubler, D. J., & Meltzer, M. (1999) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60342-5 · Cited by 318 · cited 2×
“Subsequently, the increased number of infected cells present targets for CD4 + and CD8 + T cells, resulting in large quantities of interleukin (IL)-10, IL-2, interferon (IFN)- γ and TNF that, singly or in combination, might contribute to endothelial damage and altered haemostasis.”
BackgroundSelf-citationA variant in the CD209 promoter is associated with severity of dengue disease
Sakuntabhai, A., Turbpaiboon, C., Casadémont, I., Chuansumrit, A., Lowhnoo, T., Kajaste-Rudnitski, A., Kalayanarooj, S. M., Tangnararatchakit, K., Tangthawornchaikul, N., Vasanawathana, S., et al. (2005) · Nature Genetics · doi:10.1038/ng1550 · Cited by 301
Self-citationOriginal Antigenic Sin in Dengue
Halstead, S. B., Rojanasuphot, S., & Sangkawibha, N. (1983) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1983.32.154 · Cited by 289 · cited 1×
“…owing to the presence of pre-existing antibodies and the phenomenon of original antigenic sin (during sequential flavivirus infections, B-cell clones responding to the first infection synthesize antibodies with higher affinity for the first infecting virus than for the second infecting virus) 69 .”
BackgroundSelf-citationHarris, E., Roberts, T. G., Smith, L., Selle, J., Kramer, L. D., Valle, S., Sandoval, E., & Balmaseda, A. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.9.2634-2639.1998 · Cited by 271 · cited 1×
“The most E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s commonly used NAATs are based on a single RT-PCR assay 95,96 , a nested RT-PCR assay 96 or a one-step multiplex RT-PCR assay 97 .”
MethodKroeger, A., Lenhart, A., Ochoa, M., Villegas, E., Levy, M., Alexander, N., & McCall, P. J. (2006) · BMJ · doi:10.1136/bmj.332.7552.1247 · Cited by 255 · cited 1×
“Additionally, new ‘consumer-friendly’ tools such as window curtains and water container covers treated with long-lasting insecticide are being tested 120 as well as controlled release larvicides that provide several months of control following a single application to targeted containers.”
BackgroundSelf-citationEvaluation of Commercially Available Anti–Dengue Virus Immunoglobulin M Tests
Hunsperger, E. A., Yoksan, S., Buchy, P., Nguyen, V. C., Sekaran, S. D., Enria, D. A., Pelegrino, J. L., Vázquez, S., Artsob, H., Drebot, M., et al. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1503.080923 · Cited by 243 · cited 2×
“More than 50 commercial kits are available with variable sensitivity and specificity 65,80–82 .”
BackgroundSelf-citationMorens, D. M., Halstead, S. B., Repik, P. M., Putvatana, R., & Raybourne, N. (1985) · Journal of Clinical Microbiology · doi:10.1128/jcm.22.2.250-254.1985 · Cited by 241
Self-citationStephens, H. A. F., Klaythong, R., Sirikong, M., Vaughn, D. W., Green, S., Kalayanarooj, S., Endy, T. P., Libraty, D. H., Nisalak, A., Innis, B. L., et al. (2002) · Tissue Antigens · doi:10.1034/j.1399-0039.2002.600405.x · Cited by 241 · cited 1×
“Host factors that increase the risk of severe dengue disease include female sex, several human leukocyte antigen (HLA) class I alleles, a promoter variant of the DC-SIGN receptor gene, a single-nucleotide polymorphism in the tumour necrosis factor (TNF) gene and AB blood group 31–36 .”
BackgroundChareonsirisuthigul, T., Kalayanarooj, S., & Ubol, S. (2007) · Journal of General Virology · doi:10.1099/vir.0.82537-0 · Cited by 238 · cited 2×
“The severity of secondary dengue infections has been observed to increase from month-to-month during island outbreaks 43 ; the longer the interval between the first and second infection the more severe is the accompanying disease 44,45 .”
BackgroundHeintze, C., Garrido, M. V., & Kroeger, A. (2007) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2006.08.007 · Cited by 238
Self-citationEnhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks
Guzmán, M. G., Kourí, G., Valdés, L., Bravo, J., Vázquez, S., & Halstead, S. B. (2002) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49892002000400003 · Cited by 234 · cited 2×
“The severity of secondary dengue infections has been observed to increase from month-to-month during island outbreaks 43 ; the longer the interval between the first and second infection the more severe is the accompanying disease 44,45 .”
BackgroundSelf-citationDevelopment of Real-Time Reverse Transcriptase PCR Assays To Detect and Serotype Dengue Viruses
Chien, L.-J., Liao, T.-L., Shu, P.-Y., Huang, J.-H., Gubler, D. J., & Chang, G.-J. J. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.4.1295-1304.2006 · Cited by 227
Self-citationBravo, J. R., Guzmán, M. G., & Kouri, G. P. (1987) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(87)90041-1 · Cited by 222 · cited 1×
“Host factors that reduce the risk of severe disease during a second dengue infection include race, second or third degree malnutrition, and polymorphisms in the Fc γ receptor and vitamin D receptor genes 37–42 .”
BackgroundThomas, S. J., Nisalak, A., Anderson, K. B., Libraty, D. H., Kalayanarooj, S., Vaughn, D. W., Putnak, R., Gibbons, R. V., Jarman, R., & Endy, T. P. (2009) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2009.08-0625 · Cited by 221
Bandyopadhyay, S., Lum, L. C. S., & Kroeger, A. (2006) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2006.01678.x · Cited by 221 · cited 1×
“Recent publications have suggested that the WHO syndromic case definition of DHF/DSS should be evaluated for clinical utility 58–62 .”
BackgroundSelf-citationCouvelard, A., Marianneau, P., Bedel, C., Drouet, M.-T., Vachon, F., Hénin, D., & Deubel, V. (1999) · Human Pathology · doi:10.1016/s0046-8177(99)90230-7 · Cited by 214 · cited 1×
“Virions released from infected cells might also directly damage endothelial cells and the uptake of the non-structural protein NS1 by hepatocytes might promote viral infection of the liver 47–49 .”
BackgroundAn ELISA procedure for the diagnosis of dengue infections
Kuno, G., Gómez, I., & Gubler, D. J. (1991) · Journal of Virological Methods · doi:10.1016/0166-0934(91)90011-n · Cited by 213 · cited 1×
“According to this method, a dengue infection is defined as a primary infection if the IgM:IgG OD ratio is greater than 1.2 (using patient sera at 1:100 dilution) or 1.4 (using patient sera at 1:20 dilution), or as a secondary infection if the ratio is less than 1.2 or 1.4 (REFS 88,89).”
MethodInfluentialSelf-citationHaiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission.
Halstead, S. B., Streit, T. G., Lafontant, J. G., Putvatana, R., Russell, K., Sun, W., Kanesa-Thasan, N., Hayes, C. G., & Watts, D. M. (2001) · The American journal of tropical medicine and hygiene · doi:10.4269/ajtmh.2001.65.180 · Cited by 211 · cited 1×
“Host factors that reduce the risk of severe disease during a second dengue infection include race, second or third degree malnutrition, and polymorphisms in the Fc γ receptor and vitamin D receptor genes 37–42 .”
BackgroundSelf-citationClinical spectrum and management of dengue haemorrhagic fever.
Nimmannitya, S. (1987) · PubMed · Cited by 209
Loke, H., Bethell, D., Phuong, C. X. T., Day, N., White, N., Farrar, J., & Hill, A. (2002) · The American journal of tropical medicine and hygiene · doi:10.4269/ajtmh.2002.67.102 · Cited by 202
Self-citationGuirakhoo, F., Kitchener, S., Morrison, D., Forrat, R., McCarthy, K., Nichols, R., Yoksan, S., Duan, X., Ermak, T. H., Kanesa-Thasan, N., et al. (2006) · Human Vaccines · doi:10.4161/hv.2.2.2555 · Cited by 197 · cited 1×
“Current approaches to vaccine development involve using live attenuated viruses, inactivated viruses, subunit vaccines, DNA vaccines, cloned engineered viruses and chimeric viruses using yellow fever vaccine and attenuated dengue viruses as backbones 129–134 .”
BackgroundSelf-citationSimmons, C. P., Popper, S., Dolocek, C., Chau, T. N. B., Griffiths, M., Dung, N. T. P., Long, T. H., Hoang, D. M., Chau, N. V., Thao, L. T. T., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/512162 · Cited by 195 · cited 1×
“Type I interferon-associated genes are less abundantly activated in peripheral blood mononuclear cells taken from patients with severe dengue disease compared with milder disease 46 .”
BackgroundSelf-citationRace: a risk factor for dengue hemorrhagic fever
Sierra, B. D. L. C., Kourí, G., & Guzmán, M. G. (2007) · Archives of Virology · doi:10.1007/s00705-006-0869-x · Cited by 194
Dengue Virus Identification by the Plaque Reduction Neutralization Test
Russell, P. K., & Nisalak, A. (1967) · The Journal of Immunology · doi:10.4049/jimmunol.99.2.291 · Cited by 189
Strong HLA Class I–Restricted T Cell Responses in Dengue Hemorrhagic Fever: A Double‐Edged Sword?
Loke, H., Bethell, D. B., Phuong, C. X. T., Dung, M., Schneider, J., White, N. J., Day, N. P., Farrar, J., & Hill, A. V. S. (2001) · The Journal of Infectious Diseases · doi:10.1086/324320 · Cited by 186
Self-citationShu, P.-Y., Chen, L.-K., Chang, S.-F., Yueh, Y.-Y., Chow, L., Chien, L.-J., Chin, C., Lin, T.-H., & Huang, J.-H. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.4.622-630.2003 · Cited by 183 · cited 1×
“According to this method, a dengue infection is defined as a primary infection if the IgM:IgG OD ratio is greater than 1.2 (using patient sera at 1:100 dilution) or 1.4 (using patient sera at 1:20 dilution), or as a secondary infection if the ratio is less than 1.2 or 1.4 (REFS 88,89).”
MethodInfluentialGamble, J., Bethell, D., Day, N. P. J., Loc, P. P., Phu, N. H., GARTSIDE, I. B., Farrar, J. F., & White, N. J. (2000) · Clinical Science · doi:10.1042/cs19990296 · Cited by 181 · cited 1×
“The severity of DSS is age-dependent, with vascular leakage being most severe in young children, a phenomenon that is thought to be related to the intrinsic integrity of the capillaries 26,27 .”
BackgroundSelf-citationSevere dengue: the need for new case definitions
Rigau-Pérez, J. G. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70465-0 · Cited by 180
Hall, W. C., Crowell, T. P., Watts, D. M., Barros, V. L. R., Kruger, H., Pinheiro, F., & Peters, C. J. (1991) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1991.45.408 · Cited by 172 · cited 1×
“Dengue antigens can be detected in tissues such as liver, spleen and lymph nodes as well as tissues from fatal cases (slides from paraffin-embedded, fresh or frozen tissues) using an enzyme and a colorimetric substrate with antibodies that target dengue-specific antigens 104–106 .”
Kay, B. H., Nam, V. S., Tien, T. V., Yen, N. T., Phong, T. V., Diep, V. T. B., Ninh, T. U., Bektas, A., & Aaskov, J. G. (2002) · The American journal of tropical medicine and hygiene · doi:10.4269/ajtmh.2002.66.40 · Cited by 170 · cited 1×
“Biological control agents, including larvivorous fish and copepods, have had a demonstrable role in controlling A. aegypti 116,117 , but operational difficulties — particularly the lack of facilities and expertise in mass rearing, and the need to frequently re-introduce these agents into some…”
BackgroundAutoimmune Pathogenesis in Dengue Virus Infection
Lin, C.-F., Wan, S.-W., Cheng, H.-J., Lei, H.-Y., & Lin, Y.-S. (2006) · Viral Immunology · doi:10.1089/vim.2006.19.127 · Cited by 170 · cited 2×
“…but nonetheless release inflammatory cytokines that contribute to disease severity 51 ; that severe disease is caused by DENVs of increased virulence 52 ; and the suggestion that cross-reactivity between NS1 and human platelets and endothelial cells raises antibodies that damage these cells 53 .”
BackgroundRODRÍGUEZ, M. M., BISSET, J. A., & FERNÁNDEZ, D. (2007) · Journal of the American Mosquito Control Association · doi:10.2987/5588.1 · Cited by 170 · cited 1×
“Since the early 1970s the organophosphate temephos has been widely used, but increasing levels of resistance 114,115 , householders’ rejection of the treatment of their drinking water, and difficulties in achieving high and regular levels of coverage are important technical and operational…”
BackgroundPHASE I TRIAL OF 16 FORMULATIONS OF A TETRAVALENT LIVE-ATTENUATED DENGUE VACCINE
EDELMAN, R., WASSERMAN, S. S., BODISON, S. A., PUTNAK, R. J., ECKELS, K. H., TANG, D., KANESA-THASAN, N., VAUGHN, D. W., INNIS, B. L., & SUN, W. (2003) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2003.69.48 · Cited by 168 · cited 1×
“Current approaches to vaccine development involve using live attenuated viruses, inactivated viruses, subunit vaccines, DNA vaccines, cloned engineered viruses and chimeric viruses using yellow fever vaccine and attenuated dengue viruses as backbones 129–134 .”
BackgroundDynamic effects of antibody-dependent enhancement on the fitness of viruses
Cummings, D. A. T., Schwartz, I. B., Billings, L., Shaw, L. B., & Burke, D. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507320102 · Cited by 166 · cited 1×
“The co-circulation of four DENV serotypes in a given population might be augmented by the ADE phenomenon 22 .”
BackgroundMorrison, D., Legg, T. J., Billings, C. W., Forrat, R., Yoksan, S., & Lang, J. (2010) · The Journal of Infectious Diseases · doi:10.1086/649916 · Cited by 165 · cited 1×
“Significant progress in the development of dengue vaccine candidates has been achieved lately 135,136 .”
BackgroundSelf-citationALVAREZ, M., RODRIGUEZ-ROCHE, R., BERNARDO, L., VÁZQUEZ, S., MORIER, L., GONZALEZ, D., CASTRO, O., KOURI, G., HALSTEAD, S. B., & GUZMAN, M. G. (2006) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2006.75.1113 · Cited by 162 · cited 3×
“Tertiary dengue infections can cause severe disease, but only rarely 25 .”
BackgroundSelf-citationHenchal, E. A., McCown, J. M., Seguin, M. C., Gentry, M. K., & Brandt, W. E. (1983) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1983.32.164 · Cited by 162 · cited 1×
“After an incubation period permitting virus replication, viral identification is performed using dengue-specific monoclonal antibodies in immunofluorescence and PCR assays 63,64,72,73 .”
MethodRapid detection, serotyping and quantitation of dengue viruses by TaqMan real-time one-step RT-PCR
Kong, Y. Y., Thay, C. H., Tin, T. C., & Devi, S. (2006) · Journal of Virological Methods · doi:10.1016/j.jviromet.2006.08.003 · Cited by 155 · cited 1×
“Many real-time RT-PCR assays have been developed that are either ‘singleplex’, detecting one single serotype per reaction, or ‘multiplex’, identifying all four serotypes from a single sample 99–101 .”
Rapid identification of dengue virus serotypes by using polymerase chain reaction
Morita, K., Tanaka, M. H., & Igarashi, A. (1991) · Journal of Clinical Microbiology · doi:10.1128/jcm.29.10.2107-2110.1991 · Cited by 154 · cited 1×
“The most E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s commonly used NAATs are based on a single RT-PCR assay 95,96 , a nested RT-PCR assay 96 or a one-step multiplex RT-PCR assay 97 .”
MethodWhitehead, S. S., Falgout, B., Hanley, K. A., Blaney, J. E., Markoff, L. J., & Murphy, B. R. (2002) · Journal of Virology · doi:10.1128/jvi.77.2.1653-1657.2003 · Cited by 154
Balmaseda, Á., Guzmán, M. G., HAMMOND, S. N., Robleto, G., Flores, C., Téllez, Y., Videa, E., SABORÍO, S. I., Pérez, L., Sandoval, E., et al. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.2.317-322.2003 · Cited by 154 · cited 1×
“79 , but not in urine 68 .”
BackgroundXu, H., Di, B., Pan, Y., Qiu, L., Wang, Y., Hao, W., He, L., Yuen, K., & Che, X.-Y. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00777-06 · Cited by 154
Fernández‐Mestre, M., Gendzekhadze, K., Rivas-Vetencourt, P., & Layrisse, Z. E. (2004) · Tissue Antigens · doi:10.1111/j.1399-0039.2004.00304.x · Cited by 152
Poder, S. L., Drouet, M., Roux, P., Frenkiel, M., Arborio, M., Durand‐Schneider, A., Maurice, M., Blanc, I., Grüenberg, J., & Flamand, M. (2005) · Journal of Virology · doi:10.1128/jvi.79.17.11403-11411.2005 · Cited by 152
Balmaseda, Á., HAMMOND, S. N., Pérez, M. Á., Cuadra, R., SOLANO, S., Rocha, J., Idiaquez, W., & Harris, E. (2005) · PubMed · Cited by 152
Fatal dengue hemorrhagic fever in Cuba, 1997
Guzmán, M. G., Álvarez, M., Rodríguez, R., Rosario, D., Vázquez, S., Valdés, L., Cabrera, M. V., & Kourí, G. (1999) · International Journal of Infectious Diseases · doi:10.1016/s1201-9712(99)90033-4 · Cited by 150 · cited 1×
“Serum is often used for virus isolation but plasma, leukocytes, whole blood and tissues obtained at autopsy can also be used 63,74,75 .”
Cardosa, M. J., Wang, S. M., Sum, M. S. H., & Tio, P. H. (2002) · BMC Microbiology · doi:10.1186/1471-2180-2-9 · Cited by 145 · cited 1×
“…within the flavivirus serocomplex groups, however it has been demonstrated that the IgG response to the prM membrane glycoprotein is specific to individual flaviviruses as no crossreactivity was observed in sera collected from individuals infected with dengue or Japanese encephalitis virus 85 .”
BackgroundDengue Fever in International Travelers
Jelı́nek, T. (2000) · Clinical Infectious Diseases · doi:10.1086/313889 · Cited by 145 · cited 2×
“Travellers from endemic areas might serve as vehicles for further spread 6–9 .”
BackgroundWhy dengue haemorrhagic fever in Cuba? 2. An integral analysis
Kourí, G., Guzmán, M., & Bravo, J. (1987) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(87)90042-3 · Cited by 144 · cited 1×
“Dengue infections can be life-threatening when they occur in individuals with asthma, diabetes and other chronic diseases 28–30 .”
BackgroundApoptosis in tissues from fatal dengue shock syndrome
Limonta, D., Capó, V. A., Torres, G., Pérez, A. B., & Guzmán, M. G. (2007) · Journal of Clinical Virology · doi:10.1016/j.jcv.2007.04.024 · Cited by 137 · cited 1×
“Dengue antigens can be detected in tissues such as liver, spleen and lymph nodes as well as tissues from fatal cases (slides from paraffin-embedded, fresh or frozen tissues) using an enzyme and a colorimetric substrate with antibodies that target dengue-specific antigens 104–106 .”
Blacksell, S. D., Newton, P. N., Bell, D., Kelley, J., Mammen, M. P., Vaughn, D. W., Wuthiekanun, V., Sungkakum, A., Nisalak, A., & Day, N. (2006) · Clinical Infectious Diseases · doi:10.1086/501358 · Cited by 136 · cited 1×
“More than 50 commercial kits are available with variable sensitivity and specificity 65,80–82 .”
BackgroundLee, M., Hwang, K., Chen, T., Lu, P.-L., & Chen, T. (2006) · PubMed · Cited by 134
Durbin, A. P., Whitehead, S. S., McArthur, J. H., Perreault, J. R., Blaney, J. E., Thumar, B., Murphy, B. R., & Karron, R. A. (2005) · The Journal of Infectious Diseases · doi:10.1086/427780 · Cited by 125
Nam, V. S., Yen, N. T., Hołyńska, M. K., Reid, J. W., & Kay, B. H. (2000) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2000.62.5 · Cited by 125 · cited 1×
“Biological control agents, including larvivorous fish and copepods, have had a demonstrable role in controlling A. aegypti 116,117 , but operational difficulties — particularly the lack of facilities and expertise in mass rearing, and the need to frequently re-introduce these agents into some…”
BackgroundRecent expansion of dengue virus serotype 3 in West Africa
Franco, L., Di, A., Carletti, F., Vapalahti, O. P., Renaudat, C., Zeller, H. G., & Tenório, A. (2010) · Eurosurveillance · doi:10.2807/ese.15.07.19490-en · Cited by 124 · cited 1×
“…to WHO from countries in the African and Eastern Mediterranean regions, in 2005–2006 outbreaks of suspected dengue were recorded in Pakistan, Saudi Arabia, Yemen, Sudan and Madagascar 1–4 , and a large outbreak of dengue involving >17,000 cases was documented in the Cape Verde islands in 2009 5 .”
BackgroundHERMIDA, L., Bernardo, L., MARTIN, J., Alvarez, M., PRADO, I., LOPEZ, C., Sierra, B., MARTINEZ, R., Rodríguez, R., & Zulueta, A. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.01.036 · Cited by 123
Detection of Dengue Viral RNA Using a Nucleic Acid Sequence-Based Amplification Assay
Wu, S.-J. L., Lee, E. M., Putvatana, R., Shurtliff, R. N., Porter, K. R., Wuryadi, S., Watts, D. M., King, C., Murphy, G. S., Hayes, C. G., et al. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.8.2794-2798.2001 · Cited by 121 · cited 3×
“The most E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s commonly used NAATs are based on a single RT-PCR assay 95,96 , a nested RT-PCR assay 96 or a one-step multiplex RT-PCR assay 97 .”
ResultSchneider, B. S., Soong, L., Zeidner, N. S., & Higgs, S. (2004) · Viral Immunology · doi:10.1089/vim.2004.17.565 · Cited by 120 · cited 1×
“Mosquito bites after the extrinsic incubation period result in infection, which might be promoted by mosquito salivary proteins 15 .”
BackgroundWong, S. J., Boyle, R. H., Demarest, V. L., Woodmansee, A. N., Kramer, L. D., Li, H., DREBOT, M. A., Koski, R. A., Fikrig, E., Martin, D. A., et al. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.9.4217-4223.2003 · Cited by 119 · cited 1×
“Similarly, it has been demonstrated that IgG specific for the NS5 protein can potentially discriminate between infections caused by West Nile, dengue and St Louis encephalitis viruses 86 .”
BackgroundChanama, S., Anantapreecha, S., A-nuegoonpipat, A., Sa-gnasang, A., Kurane, I., & Sawanpanyalert, P. (2004) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.03.005 · Cited by 108 · cited 2×
“The kinetics of the IgM response are more variable; as IgM levels are significantly lower in secondary dengue infections, false-negative test results for dengue-specific IgM have been reported during secondary infections 55,66,67 .”
BackgroundBalmaseda, Á., HAMMOND, S. N., Pérez, M. Á., Cuadra, R., SOLANO, S., ROCHA, J., Idiaquez, W., & Harris, E. (2005) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2005.73.1059 · Cited by 107
Rosen, L. E., Drouet, M., & Deubel, V. (1999) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1999.61.720 · Cited by 106 · cited 1×
“Serum is often used for virus isolation but plasma, leukocytes, whole blood and tissues obtained at autopsy can also be used 63,74,75 .”
LaFleur, C., Granados, J., Vargas-Alarcon, G., Ruíz-Morales, J., Villarreal-Garza, C., Higuera, L., Hernández-Pacheco, G., Cutiño-Moguel, T., Rangel, H., Figueroa, R., et al. (2002) · Human Immunology · doi:10.1016/s0198-8859(02)00682-1 · Cited by 103
Vázquez, S., Cabezas, S., Pérez, A. B., Pupo, M., Ruiz, D., Calzada, N., Bernardo, L., Castro, O., Gonzalez, D. C., Serrano, T., et al. (2006) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2006.05.005 · Cited by 101 · cited 2×
“79 , but not in urine 68 .”
BackgroundComplement and dengue haemorrhagic fever/shock syndrome.
Malasit, P. (1987) · PubMed · Cited by 100
(2004) · Cited by 99
Nutritional Status of Children with Dengue Hemorrhagic Fever
Thisyakorn, U., & Nimmannitya, S. (1993) · Clinical Infectious Diseases · doi:10.1093/clind/16.2.295 · Cited by 97
Blood Group AB Is Associated with Increased Risk for Severe Dengue Disease in Secondary Infections
Kalayanarooj, S., Gibbons, R. V., Vaughn, D. W., Green, S., Nisalak, A., Jarman, R. G., Mammen, M. P., & Perng, G. (2007) · The Journal of Infectious Diseases · doi:10.1086/512244 · Cited by 94 · cited 1×
“Host factors that increase the risk of severe dengue disease include female sex, several human leukocyte antigen (HLA) class I alleles, a promoter variant of the DC-SIGN receptor gene, a single-nucleotide polymorphism in the tumour necrosis factor (TNF) gene and AB blood group 31–36 .”
BackgroundDo escape mutants explain rapid increases in dengue casefatality rates within epidemics?
Guzmán, M. G., Kourí, G., & Halstead, S. B. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02303-5 · Cited by 92 · cited 1×
“The severity of secondary dengue infections has been observed to increase from month-to-month during island outbreaks 43 ; the longer the interval between the first and second infection the more severe is the accompanying disease 44,45 .”
BackgroundSelf-citationFalconar, A. K. I., de Plata, E., & Romero-Vivas, C. M. (2006) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00105-06 · Cited by 82 · cited 2×
“However, in a recent publication the authors indicated that the IgM:IgG ratio varies depending on whether the patient has a serologically non-classical or classical dengue infection, and redefined the ratios 84 .”
BackgroundDengue virus: molecular basis of cell entry and pathogenesis, 25–27 June 2003, Vienna, Austria
Halstead, S. B., Heinz, F. X., Barrett, A. D. T., & Roehrig, J. T. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.03.069 · Cited by 80 · cited 1×
“Because of the important role of neutralizing antibodies as surrogates of protection, the validation of neutralization tests is a priority 128 .”
BackgroundSelf-citationRaviprakash, K. S., Apt, D., Brinkman, A., Skinner, C. B., Yang, S., Dawes, G. N., Ewing, D. F., Wu, S.-J. L., Bass, S., Punnonen, J., et al. (2006) · Virology · doi:10.1016/j.virol.2006.05.005 · Cited by 76
Virus evolution during a severe dengue epidemic in Cuba, 1997
Rodríguez, R., Álvarez, M., Грицун, Т. С., Halstead, S. B., Kourí, G., Gould, E. A., & Guzmán, M. G. (2005) · Virology · doi:10.1016/j.virol.2005.01.037 · Cited by 71 · cited 1×
“The molecular epidemiology of these serotypes has been studied in an attempt to understand their evolutionary relationships 11 .”
BackgroundSelf-citationShu, P., Chen, L., Chang, S., Yueh, Y., Chow, L., Chien, L., Chin, C., Yang, H., Lin, T.-H., & Huang, J.-H. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.5.1840-1844.2002 · Cited by 66 · cited 1×
“Additional independent studies are needed to confirm the performance of these kits and to further validate the diagnostic and prognostic significance of NS1 and NS1-specific antibody detection 107–109 .”
Vaccines against dengue: a review of current candidate vaccines at advanced development stages
Hombach, J. (2007) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49892007000300011 · Cited by 63 · cited 3×
“As a result of the failure of vector control, the continuing spread and increasing intensity of dengue has renewed interest and investment in dengue vaccine development, making a safe, effective and affordable tetravalent dengue vaccine a global public health priority 122 .”
BackgroundInfluentialScientific consultation on immunological correlates of protection induced by dengue vaccines
Hombach, J., Cardosa, M. J., Sabchareon, A., Vaughn, D. W., & Barrett, A. D. T. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.02.079 · Cited by 57 · cited 2×
“The poor understanding of the mechanisms involved in inducing protective immunity against dengue infection poses additional challenges 123 .”
BackgroundBlacksell, S. D., Bell, D., Kelley, J., Mammen, M. P., Gibbons, R. V., Jarman, R. G., Vaughn, D. W., Jenjaroen, K., Nisalak, A., Thongpaseuth, S., et al. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00482-06 · Cited by 56
Mulla, M. S., Thavara, U., Tawatsin, A., Kong-ngamsuk, W., & Chompoosri, J. (2001) · PubMed · Cited by 53
Raengsakulrach, B., Nisalak, A., Maneekarn, N., Yenchitsomanus, P., Limsomwong, C., Jairungsri, A., Thirawuth, V., Green, S., Kalayanarooj, S., Suntayakorn, S., et al. (2002) · Journal of Virological Methods · doi:10.1016/s0166-0934(02)00104-0 · Cited by 50 · cited 1×
“The sensitivity of RT-PCR assays in comparison to virus isolation in mosquito cell culture varies between 25% and 79% 98 .”
BackgroundEthnicity and Difference in Dengue Virus-Specific Memory T Cell Responses in Cuban Individuals
Sierra, B., García, G., Pérez, A. B., Morier, L., Álvarez, M., Kourí, G., & Guzmán, M. G. (2006) · Viral Immunology · doi:10.1089/vim.2006.19.662 · Cited by 45
Kao, C., Wu, M.-C., Chiu, Y., Lin, J.-L., Wu, Y.-C., Yueh, Y.-Y., Chen, L., Shaio, M., & King, C. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.10.3672-3677.2001 · Cited by 44 · cited 1×
“After an incubation period permitting virus replication, viral identification is performed using dengue-specific monoclonal antibodies in immunofluorescence and PCR assays 63,64,72,73 .”
MethodLa prevención de la mortalidad por dengue: un espacio y un reto para la atención primaria de salud
Torres, E. (2006) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49892006000700013 · Cited by 42
Phase 1 Trial of the Dengue Virus Type 4 Vaccine Candidate rDEN4Δ30-4995 in Healthy Adult Volunteers
Wright, P. F., Durbin, A. P., Whitehead, S. S., Ikizler, M. R., Henderson, S. E., Blaney, J. E., Thumar, B., Ankrah, S., Rock, M. T., McKinney, B. A., et al. (2009) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2009.09-0131 · Cited by 42 · cited 1×
“Significant progress in the development of dengue vaccine candidates has been achieved lately 135,136 .”
Detección de IgM contra el virus del dengue en sangre entera absorbida en papel de filtro
Vázquez, S., Sáenz, E., Huelva, G., González, A., Kourí, G., & Guzmán, M. G. (1998) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49891998000300005 · Cited by 39 · cited 1×
“77,78 and in saliva (sensitivity 90.3% and specificity 92.0”
BackgroundInfluentialDengue Antibody Prevalence in German Travelers
Wichmann, O., Lauschke, A., Frank, C., Shu, P., Niedrig, M., Huang, J.-H., Stark, K., & Jelı́nek, T. (2005) · Emerging infectious diseases · doi:10.3201/eid1105.050097 · Cited by 34
[Inhibition ELISA. Its utility for classifying a case of dengue].
Vázquez, S., Bravo, J., Pérez, A. B., & Guzmán, M. G. (1997) · PubMed · Cited by 32
Dengue in the Caribbean: virus isolation in a mosquito (Aedes pseudoscutellaris) cell line
Race, M. W., Williams, M., & Agostini, C. (1979) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(79)90122-6 · Cited by 28 · cited 1×
“The Aedes albopictus mosquito C6/36 cell line is the method of choice for DENV isolation, although other mosquito (such as Aedes pseudoscutellaris AP61) and mammalian (including Vero cells, LLC-MK2 cells and BHK21 cells) cell lines can also be used 70,71 .”
MethodMj, C., Tio, P. H., Nimmannitya, S., Nisalak, A., & Innis, B. L. (1992) · PubMed · Cited by 27
dos Santos, F. B., Miagostovich, M. P., Nogueira, R. M. R., Schatzmayr, H. G., Riley, L. W., & Harris, E. (2004) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2004.71.144 · Cited by 25 · cited 1×
“Finally, dengue-specific IgG was shown to have high specificity in an assay using a recombinant polypeptide located in the N-terminal region of the envelope protein 87 .”
MethodPelegrino, J. L., Arteaga, E., Rodríguez, A. J. P., González, E., Frontela, M., & Guzmán, M. (1997) · PubMed · Cited by 16
Self-citationIgM antibodies to dengue virus in dried blood on filter paper
Herrera, R., Cabrera, M. V., García, S. G., & Gilart, M. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.12.042 · Cited by 14 · cited 1×
“77,78 and in saliva (sensitivity 90.3% and specificity 92.0”
BackgroundInfluentialIndian perspective on the need for new case definitions of severe dengue
Thangaratham, P. S., & Tyagi, B. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70005-1 · Cited by 12 · cited 1×
“Recent publications have suggested that the WHO syndromic case definition of DHF/DSS should be evaluated for clinical utility 58–62 .”
Background
Research works printed but not linked: 3
- Vorndam, V. & Kuno, G. In Dengue and Dengue Hemorrhagic Fever (eds Gubler, D. J. & Kuno, G.) 313–333 (CAB International, New York, USA, 1997).
- Gubler, D. J. Serologic diagnosis of dengue/dengue haemorrhagic fever. Dengue Bull. 20, 20–23 (1996).
- Singh, K. R. P. & Paul, S. D. Multiplication of arboviruses in cell lines from Aedes albopictus and Aedes aegypti. Curr. Sci. 37, 65–67 (1968).
Cited by
Successful establishment of Wolbachia in Aedes populations to suppress dengue transmission
Hoffmann, A. A., Montgomery, B. L., Popovici, J., Iturbe-Ormaetxe, I., Johnson, P. H., Muzzi, F., Greenfield, M., Durkan, M., Leong, Y. S., Dong, Y., et al. (2011) · Nature · doi:10.1038/nature10356 · Cited by 1,603
The wMel Wolbachia strain blocks dengue and invades caged Aedes aegypti populations
Walker, T., Johnson, P. H., Moreira, L. A., Iturbe-Ormaetxe, I., Frentiu, F. D., McMeniman, C. J., Leong, Y. S., Dong, Y., Axford, J., Kriesner, P., et al. (2011) · Nature · doi:10.1038/nature10355 · Cited by 1,400
Antibody-dependent enhancement of severe dengue disease in humans
Katzelnick, L. C., Gresh, L., Halloran, M. E., Mercado, J. C., Kuan, G., Gordon, A., Balmaseda, A., & Harris, E. (2017) · Science · doi:10.1126/science.aan6836 · Cited by 1,205
Epidemiology of dengue: past, present and future prospects
Wilder-Smith, A., Murray, & Quam, M. (2013) · Clinical Epidemiology · doi:10.2147/clep.s34440 · Cited by 1,033
“13 Notably, in 2009, the Cape Verde archipelago had a large dengue outbreak involving more than 17,000 cases and linked to DENV-3.”
Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
Villar, L., Dayan, G. H., Arredondo-García, J. L., Rivera, D. M., Cunha, R., Deseda, C., Reynales, H., Costa, M. S., Morales-Ramírez, J. O., Carrasquilla, G., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411037 · Cited by 942
Metadata
- Authors
- Guzman, M. G., Halstead, S. B., Artsob, H., Buchy, P., Farrar, J., Gubler, D. J., Hunsperger, E., Kroeger, A., Margolis, H. S., Martínez, E., Nathan, M. B., Pelegrino, J. L., Simmons, C., Yoksan, S., & Peeling, R. W.
- Affiliations
- Public Health Agency of Canada (CA)
- Institut Pasteur du Cambodge (KH)
- Oxford University Clinical Research Unit (VN)
- National University of Singapore (SG)
- Centers for Disease Control and Prevention (US)
- World Bank (US)
- Instituto de Medicina Tropical “Pedro Kourí” (CU)
- World Health Organization (CH)
- Mahidol University (TH)
- Corresponding author
- Peeling, Rosanna W.
- ORCID
- Venue
- Nature Reviews Microbiology
- Published
- 2010-12
- Volume
- 8
- Issue
- S12
- Pages
- S7-S16
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- PMC
- PMC4333201
- OpenAlex
- W2042479028
- Cited by
- 2,082
- References
- 130
- Citations by year
- 2026: 68 · 2025: 104 · 2024: 94 · 2023: 135 · 2022: 116 · 2021: 133 · 2020: 140 · 2019: 127 · 2018: 142 · 2017: 151 · 2016: 163 · 2015: 189 · 2014: 186 · 2013: 161 · 2012: 132
- FWCI
- 15.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Funders
- Wellcome Trust (084368)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Mosquito-borne diseases and control
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Dengue and Mosquito Control Research
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Vectors
- Keywords
- dengue, dengue hemorrhagic fever, arboviruses, dengue serotypes, vector-borne diseases, dengue surveillance, outbreak response, integrated vector management, early diagnosis, dengue vaccine, antiviral agents, dengue control
- MeSH terms
- Americas, Asia, Southeastern, Dengue, Dengue Virus, Hospitalization, Humans, Insect Control, Pacific Islands
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.